PharmaSGP Holding Past Earnings Performance

Past criteria checks 5/6

PharmaSGP Holding has been growing earnings at an average annual rate of 3.4%, while the Pharmaceuticals industry saw earnings growing at 10.8% annually. Revenues have been growing at an average rate of 20.8% per year. PharmaSGP Holding's return on equity is 55.9%, and it has net margins of 16.6%.

Key information

3.4%

Earnings growth rate

3.3%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate20.8%
Return on equity55.9%
Net Margin16.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How PharmaSGP Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:PSG Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2411018560
31 Mar 2410718540
31 Dec 2310116510
30 Sep 239815510
30 Jun 239414480
31 Mar 238913460
31 Dec 228612440
30 Sep 228311640
30 Jun 228111420
31 Mar 227411460
31 Dec 216511360
30 Sep 21618360
30 Jun 21568340
31 Mar 21599360
31 Dec 206311350
30 Sep 206516310
30 Jun 206517310
31 Mar 206417220
31 Dec 196317300
31 Dec 186115290
31 Dec 175312280

Quality Earnings: PSG has high quality earnings.

Growing Profit Margin: PSG's current net profit margins (16.6%) are higher than last year (15.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PSG's earnings have grown by 3.4% per year over the past 5 years.

Accelerating Growth: PSG's earnings growth over the past year (28.7%) exceeds its 5-year average (3.4% per year).

Earnings vs Industry: PSG earnings growth over the past year (28.7%) exceeded the Pharmaceuticals industry 1.5%.


Return on Equity

High ROE: Whilst PSG's Return on Equity (55.85%) is outstanding, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies